Walleye Trading LLC Liquidia Corp Call Options Transaction History

Walleye Trading LLC

  • $41.2 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.96 - $15.71 $149,500 - $196,375
-12,500 Reduced 55.8%
9,900 $118,000
Q1 2024

May 15, 2024
BUY
$11.35 - $16.73 $248,565 - $366,387
21,900 Added 4380.0%
22,400 $330,000
Q4 2023

Feb 14, 2024
SELL
$5.77 - $12.19 $5,193 - $10,971
-900 Reduced 64.29%
500 $6,000
Q3 2023

Nov 14, 2023
BUY
$6.27 - $8.15 $8,778 - $11,410
1,400 New
1,400 $8,000

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email